韩国国民健康保险数据中癌症患者生命最后一年的医疗费用

数据集获取（Figshare）

• 源站标题：Medical care costs of cancer in the last year of life using national health insurance data in Korea
• DOI：10.1371/journal.pone.0197891
• 发布日期：2018-06-07
• 文件数：3 个
• 文件总体积：149.51 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Medical_care_costs_of_cancer_in_the_last_year_of_life_using_national_health_insurance_data_in_Korea/6457076

命令行下载

curl -L -o "pone.0197891.s001.docx" "https://ndownloader.figshare.com/files/11879741"
curl -L -o "pone.0197891.s002.docx" "https://ndownloader.figshare.com/files/11879744"
curl -L -o "pone.0197891.s003.docx" "https://ndownloader.figshare.com/files/11879747"

文件清单

• pone.0197891.s001.docx（50.49 KB）
• pone.0197891.s002.docx（50.26 KB）
• pone.0197891.s003.docx（48.75 KB）

文件总体积 149.51 KB（源站 API 实测）。

数据说明

Background
Medical care of cancer patients at the end-of-life is costly. This study aims to describe the monthly trends of EOL medical care, drug therapy, and chemotherapy costs per patient with cancer in the last year of life in the inpatients vs. outpatient setting for the 13 most prevalent cancers in Korea.
Methods
Using the Health Insurance Review and Assessment Service (HIRA) database, we identified the patients who had been treated for the primary diagnoses of one of the 13 most prevalent cancers in Korea and died between January 1, 2013 and December 31, 2015. We calculated the mean monthly costs of medical care, drug therapy, and chemotherapy per patient in the last year of life by cancer site and patient setting (inpatient vs. outpatient).
Results
For most cancers, the monthly inpatient costs per patient remain stable or increased gradually from 12 months to 3 months prior to death and then increased steeply from 2 months prior to death. The mean monthly inpatient costs per patient were highest for acute myeloid leukemia (AML) throughout the last year of life; all solid tumors had similar trends of monthly inpatient costs. The mean monthly inpatient costs for AML increased from $5,465 (SD, $5,248) in 12 months prior to death to $15,033 (SD, $11,864) in the last month. The monthly outpatient costs per patient showed similar, gradually decreasing trends for most cancers. The mean outpatient costs were highest for kidney cancer; the costs sharply decreased from $954 (SD, $1,346) in 12 months prior to death to $424 (SD, $736) in the last month. The proportion of inpatients receiving chemotherapy in the last month of life was highest for AML (77%), followed by liver cancer (67%) and breast cancer (56%).
Conclusion
The monthly inpatient medical care costs per patient with cancer increased as the patient approached death, while the monthly outpatient costs decreased. A considerable proportion of inpatient received chemotherapy in the last month of life. Efforts are needed to optimize EOL care for cancer patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0197891（source: https://plos.figshare.com/articles/dataset/Medical_care_costs_of_cancer_in_the_last_year_of_life_using_national_health_insurance_data_in_Korea/6457076）。